In our institute, one hundred sixty-four balloon dilatations ofstenotic lesions in vascular access have been performed since November1991. All of these procedures were done with high-pressure balloon catheters. In addition to seventy-four cases treated with only percutaneous transluminal angioplasty, there were thirty-four cases which were treated by thrombectomyand/or surgical revision with subsequent intraoperative balloon angioplasty. These angioplastic procedures were initially successful in 142 (87%) of 164 stenoses. The patency rate after 3 months was 68% ; after 6 months, 42% ; and after 1 year, 25%. There were no serious adverse reactions in our series. This procedure can be safely done with minimal traumatization and, although long-term patency rates are low, repeated dilatations can be performed with ease, whenrestenosis occurs, to keep a fistula functioning for a long time in appropriate patients. (Internal Medicine 33: 284-287, 1994) 
Introduction
Maintenanceof a patent vascular access is one of the most annoying and important issues facing the physician whocares for patients on maintenance hemodialysis. Percutaneous transluminal angioplasty (PTA) is a widely used and wellestablished technique for the dilatation of stenoses in the arterial tree. More recently, a number of reports have discussed the applications of the procedure and successful dilatations of stenotic lesions in dialysis access fistulas. This report summarizesour experience over one year and a half at Nagoya Kyoritsu Hospital with transluminal angioplasty using high-pressure balloon catheters for the treatment of venous stenotic lesions in vascular access.
Materials and Methods
From November 1991 to June 1993, 164 dilatations were performed on 1 15 patients with malfunctioning hemodialysis fistulas. There were 58 men and 57 womenin the study, with a mean age of 58.5 years.
Clinical signs of insufficiency included decreased blood flow rates, elevated venous pressure, arm edema, enlarging venous aneurysms or graft pseudoaneurysms, and graft thrombosis. Almost all patients with these signs except complete occlusion underwent an angiographic examination of the involved extremity.
Catheterization of the venous limb fistula or graft was achieved with a 5.8 Fr high-pressure Olbert® balloon catheter with a diameter of 6mmor more at inflation. The puncture site dependedon the stenosis location and the catheter was advanced beyond the stenosis by antegrade or retrograde route by using a 0.025 inch guidewire. Balloon inflation was achieved under fluoroscopic image with a hand-held syringe, connected to a calibrated pressure regulator. Most of the patients were treated by inflation of the balloon with a high pressure (up to 9 to 12 atmospheres with Olbert's catheter). The balloon was left inflated for one to three minutes; several inflations were sometimes required. All patients received 2,000 to 3,000 units of heparin prior to balloon inflation. Following the angioplasty angiographywas repeated to monitor success and to rule out complications. None of this procedure took longer than one hour to complete. The use of gelatin promoted clotting and reduced compression time after the procedure.
In the cases with a completely thrombosed graft, an open Fogarty balloon thrombectomy was performed. Using only local anesthesia, the graft was exposed and incised in the operating room. Thrombuswas removed from both limbs using a Fogarty balloon catheter. Thereafter high-pressure balloon angioplasty was performed for the involved stenosis under fluoroscopic guidance through the incision site. Seventy-four cases were treated with simple percutaneous transluminal angioplasty. There were thirteen cases with combined thrombectomy and subsequent angioplasty, and seventeen cases with the combination of surgical revision of another stenotic site and balloon angioplasty. Four cases with multiple stenotic lesions were treated by both thrombectomy and surgical revision with intraoperative balloon angioplasty ( Table 1) .
Results
One hundred sixty-four dilatations were performed on 1 15 patients; initial and follow-up results are summarized in Table  2 . One hundred fourty-two of 164 dilatations (87%) were initially successful, as determined by morphologic improvement of the lesion and reduction in pressure gradient. Failure of angioplasty ( Repair of stenotic site due to failure of angioplasty 7
PTA:percutaneous transluminal angioplasty. *In multiple stenotic lesions some were dilated with angioplasty and others were treated by surgical revision. Repeated dilatations, two to seven times, were performed in the group with restenoses. Table 6 . Annual Change of Cases in Our Institute listed in Table 2 . In regard to the causes of chronic renal failure, the 6-month patency rates of each disease are shown in Table 4 .
In the group with restenoses, repeat dilatations were performed after recurrent insufficiency and some of them were successful (Table 5) . One patient underwent angioplasty seven times for her thigh vascular access about one year and a half. She has had severe malignant rheumatoid arthritis, and adequate access sites were completely exhausted in both upper extremities.
Discussion
The maintenance of an access site is one of the most challenging concerns in the care of hemodialysis-dependent patients. The ideal long-term patent access is the internal arteriovenous fistula (AVF); however, when this kind of fistula cannot be constructed, prosthetic grafts (polytetrafluoroethylene [PTFE] ) are currently used. The most frequent long-term complication of both AVF and PTFE may be thrombosis. This is usually due to a venous stenosis. Especially stenotic lesions of PTFEgrafts can occur at the vein-graft anastomosis associated with venous intimal hyperplasia and eventual fibrosis, or can less frequently occur more proximally in the autogenous vein. Thrombectomy followed by surgical revision has been commonly employed, but this procedure is relatively complex and causes patient discomfort. Furthermore, repeated surgical pro- Widely varying success rates have been reported for balloon angioplasty of stenoses in dialysis fistulas (1-10). In our entire series, transluminal angioplasty with a high-pressure balloon yielded an initial success rate of 87%, a 3-month patency rate of 68%; a 6-month, 42%; and a 12-month, only 25% (Table 2 ). There were no significant differences by site of lesion except for the 1 2-month patency rate. Our data also indicates that stenoses of a PTFE graft itself are candidates for transluminal dilatation with a high degree of initial success at an early stage of malfunction (for example, fresh thrombus).
The annual changes of hemodialysis patients and the patients who underwent transluminal angioplasty or surgery in our institute are detailed in Table 6 . Chronic hemodialysis patients totaling 549 in 1993 was up 13.2% from 1990. As previously mentioned, 1 15 patients underwent transluminal angioplasty from November 1991 to June 1993. The number of hemodialysis-dependent patients and cases of balloon angioplasty has been annually increasing. On the other hand, cases of shunt surgery are decreasing, and there is a remarkable decrease in the numberof patients whohave undergone surgical revisions more than two times within one year.
Conclusion
PTAis technically easy to do; it is a safe procedure for avoiding surgical revision and prolonging the life of vascular access, and it is less frightening to patients than surgery.
Although the long-term patency rates of PTAare not high, balloon dilatation is a simple procedure with minimal traumatization and can be repeated over and over again to keep a wellfunctioning fistula. The nonsurgical prolongation of the life of vascular access is a substantial service to patients whohave already undergone and are still likely to undergo numerous vexing surgical revisions during their lifetime. Therefore, transluminal angioplasty should be the first choice of treatment of failed vascular access.
